Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide

Neuroscience Letters

Volumn 332, Issue 2, 2002, Pages 127-130

  Milton, Nathaniel G N ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Alzheimer's; Amyloid ; Anandamide; Cannabinoid; Corticotrophin releasing hormone; Mitogen activated protein kinase; Neurons; Noladin ether

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; AMYLOID BETA PROTEIN; ANANDAMIDE; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR; ETHER DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NOLADIN ETHER; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE CELL; NERVE DEGENERATION; NEUROTOXICITY; PRIORITY JOURNAL; TERATOCARCINOMA;

AMYLOID BETA-PROTEIN; ARACHIDONIC ACIDS; CANNABINOIDS; CORTICOTROPIN-RELEASING HORMONE; ENZYME INHIBITORS; FLAVONOIDS; GLYCERIDES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NERVOUS SYSTEM DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0037206662     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00936-9     Document Type: Article

References (20)

1. Abe K., Saito H. Amyloid β neurotoxicity not mediated by the mitogen-activated protein kinase cascade in cultured rat hippocampal and cortical neurons. Neurosci. Lett. 292:2000;1-4.
2. Ameri A. The effects of cannabinoids on the brain. Prog. Neurobiol. 58:1999;315-348.
3. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:2002;507-511.
4. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
5. Fezza F., Bisogno T., Minassi A., Appendino G., Mechoulam R., Di Marzo V. Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Lett. 513:2002;294-298.
6. Guzman M., Sanchez C., Galve-Roperh I. Control of the cell survival/death decision by cannabinoids. J. Mol. Med. 78:2001;613-625.
7. 1 receptor. Proc. Natl. Acad. Sci. USA. 98:2001;3662-3665.
8. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors. Pharmacol. Rev. 54:2002;161-202.
9. Jacobsson S.O.P., Wallin T., Fowler C.J. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J. Pharmacol. Exp. Ther. 299:2001;951-959.
10. Mattson M.P. Cellular actions of β-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives. Physiol. Rev. 77:1997;1081-1132.
11. Mauler F., Mittendorf J., Horvath E., De Vry J. Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties. J. Pharmacol. Exp. Ther. 302:2002;359-368.
12. Milton N.G.N. Amyloid-β binds catalase with high affinity and inhibits hydrogen peroxide breakdown. Biochem. J. 344:1999;293-296.
13. Milton N.G.N. The amyloid-β peptide binds to human cyclin B1 and increases human cyclin-dependent kinase-1 activity. Neurosci. Lett. 322:2002;131-133.
14. Milton N.G.N., Hillhouse E.W., Milton A.S. A possible role for peripheral corticotrophin-releasing factor-41 in the febrile response of conscious rabbits. J. Physiol. (Lond.). 465:1993;419-430.
15. Milton N.G.N., Mayor N.P., Rawlinson J. Identification of amyloid-β binding sites using an antisense peptide approach. NeuroReport. 12:2001;2561-2566.
16. Nagayama T., Sinor A.D., Simon R.P., Chen J., Graham S.H., Jin K., Greenberg D.A. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neurosci. 19:1999;2987-2995.
17. Pedersen W.A., Wan R., Zhang P., Mattson M.P. Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J. Neurosci. 22:2002;404-412.
18. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399:1999;A23-A31.
19. Skovronsky D.M., Doms R.W., Lee V.M. Detection of a novel intraneuronal pool of insoluble amyloid β protein that accumulates with time in culture. J. Cell Biol. 141:1998;1031-1039.
20. Yan X.Z., Qiao J.T., Dou Y., Qiao Z.D. β-Amyloid peptide fragment 31-35 induces apoptosis in cultured cortical neurons. Neuroscience. 92:1999;177-184.